Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis DOI

Xia Niu,

Yanan Meng,

Jinjin Cui

и другие.

ACS Nano, Год журнала: 2023, Номер 17(23), С. 23608 - 23625

Опубликована: Ноя. 23, 2023

Liver fibrosis is a major contributor to the morbidity and mortality associated with liver diseases, yet effective treatment options remain limited. Hepatic stellate cells (HSCs) are promising target for hepatic fibrogenesis due their pivotal role in disease progression. Our previous research has demonstrated potential of Dihydrotanshinone I (DHI), lipophilic component derived from natural herb Salvia miltiorrhiza Bunge, treating by inhibiting YAP/TEAD2 interaction HSCs. However, clinical application DHI faces challenges its poor aqueous solubility lack specificity Additionally, recent studies have implicated impact microbiota, distinct gut on pathogenesis diseases. In this study, we developed an HSC- microbiome-specific delivery system conjugating prebiotic-like cyclodextrin (CD) vitamin A, utilizing PEG2000 as linker (VAP2000@CD). results demonstrate that VAP2000@CD markedly enhances cellular uptake human HSC line LX-2 deposition fibrotic vivo. Subsequently, intervention DHI-VAP2000@CD shown notable reduction bile duct-like structure proliferation, collagen accumulation, expression fibrogenesis-associated genes rats subjected duct ligation. These effects may be attributed regulation interaction. Importantly, also restored microbial homeostasis liver, promoting amelioration inflammation. Overall, our findings indicate represents therapeutic approach specifically targeting HSCs restoring balance.

Язык: Английский

Macrophage Polarization and Its Role in Liver Disease DOI Creative Commons
Cheng Wang, Cheng Ma, Lihong Gong

и другие.

Frontiers in Immunology, Год журнала: 2021, Номер 12

Опубликована: Дек. 14, 2021

Macrophages are important immune cells in innate immunity, and have remarkable heterogeneity polarization. Under pathological conditions, addition to the resident macrophages, other macrophages also recruited diseased tissues, polarize various phenotypes (mainly M1 M2) under stimulation of factors microenvironment, thus playing different roles functions. Liver diseases hepatic changes caused by a variety pathogenic (viruses, alcohol, drugs, etc.), including acute liver injury, viral hepatitis, alcoholic disease, metabolic-associated fatty fibrosis, hepatocellular carcinoma. Recent studies shown that macrophage polarization plays an role initiation development diseases. However, because both pathogenesis complex, mechanism need be further clarified. Therefore, origin mechanisms reviewed first this paper. It is found involves several molecular mechanisms, mainly TLR4/NF-κB, JAK/STATs, TGF-β/Smads, PPARγ, Notch, miRNA signaling pathways. In addition, paper expounds diseases, which aims provide references for research contributing therapeutic strategy ameliorating modulating

Язык: Английский

Процитировано

381

Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis DOI Creative Commons

Hyunsoo Rho,

Alexander R. Terry, Constantinos Chronis

и другие.

Cell Metabolism, Год журнала: 2023, Номер 35(8), С. 1406 - 1423.e8

Опубликована: Июль 17, 2023

Язык: Английский

Процитировано

127

Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis DOI Creative Commons
Yadong Fu, Xiaoxi Zhou, Lin Wang

и другие.

Redox Biology, Год журнала: 2024, Номер 69, С. 103029 - 103029

Опубликована: Янв. 4, 2024

Hepatocyte ferroptosis promotes the pathogenesis and progression of liver fibrosis. Salvianolic acid B (Sal B) exerts antifibrotic effects. However, pharmacological mechanism target has not yet been fully elucidated. In this study, fibrosis was induced by CCl4 in wild-type mice hepatocyte-specific extracellular matrix protein 1 (Ecm1)-deficient mice, which were separately treated with Sal B, ferrostatin-1, sorafenib or cilengitide. Erastin- CCl4-induced hepatocyte models without Ecm1 gene knockdown evaluated vitro. Subsequently, interaction between xCT binding kinetics determined. We found that significantly attenuated mice. deletion hepatocytes abolished effect B. Mechanistically, protected against upregulating Ecm1. Further research revealed as a direct for treating Interestingly, interacted to regulate ferroptosis. vitro treatment, abrogated after LO2 cells. Therefore, alleviates targeting up-regulation inhibiting The regulates

Язык: Английский

Процитировано

29

Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway DOI Creative Commons
Ming Xiang, Tingting Liu, Cheng Tian

и другие.

Pharmacological Research, Год журнала: 2022, Номер 177, С. 106092 - 106092

Опубликована: Янв. 21, 2022

Язык: Английский

Процитировано

57

Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease DOI Creative Commons
Mengqin Yuan,

Xue Hu,

Lichao Yao

и другие.

Stem Cell Research & Therapy, Год журнала: 2022, Номер 13(1)

Опубликована: Май 3, 2022

Abstract Mesenchymal stem cell (MSC) transplantation, as an alternative strategy to orthotopic liver has been evaluated for treating end-stage disease. Although the therapeutic mechanism of MSC transplantation remains unclear, accumulating evidence demonstrated that MSCs can regenerate tissues and self-renew repair through differentiation into hepatocyte-like cells, immune regulation, anti-fibrotic mechanisms. Multiple clinical trials have confirmed restores function alleviates damage. A sufficient number must be home target after administration successful application. However, inefficient homing systemic is a major limitation in therapy. Here, we review mechanisms application status treatment disease comprehensively summarize molecular homing, various strategies promoting improve

Язык: Английский

Процитировано

56

Extracellular Matrix Dynamics as an Emerging yet Understudied Hallmark of Aging and Longevity DOI Creative Commons
Cyril Statzer,

Ji Young Cecilia Park,

Collin Y. Ewald

и другие.

Aging and Disease, Год журнала: 2023, Номер 14(3), С. 670 - 670

Опубликована: Янв. 1, 2023

The biomechanical properties of extracellular matrices (ECM) and their consequences for cellular homeostasis have recently emerged as a driver aging. Here we review the age-dependent deterioration ECM in context our current understanding aging processes. We discuss reciprocal interactions longevity interventions with remodeling. And relevance dynamics captured by matrisome matreotypes associated health, disease, longevity. Furthermore, highlight that many established compounds promote homeostasis. A large body evidence to qualify hallmark is emerging, data invertebrates promising. However, direct experimental proof activating sufficient slow mammals lacking. conclude further research required anticipate conceptual framework biomechanics will provide new strategies health during

Язык: Английский

Процитировано

40

The role of altered lipid composition and distribution in liver fibrosis revealed by multimodal nonlinear optical microscopy DOI Creative Commons
Hao Jia, Juan Liu, Tinghe Fang

и другие.

Science Advances, Год журнала: 2023, Номер 9(2)

Опубликована: Янв. 13, 2023

Intracellular lipid accumulation is commonly seen in fibrotic livers, but its exact role liver fibrosis remains elusive. Here, we established a multimodal nonlinear optical microscopy to quantitatively map distribution of biomolecules livers. Our data revealed that unsaturated triglycerides were predominantly accumulated central vein area during not portal area. Moreover, the homeostasis was remarkably dysregulated late-stage compared early-stage fibrosis, including increased with decreased unsaturation degree and membrane fluidity. Such alterations likely due up-regulated lipogenesis, desaturation, peroxidation, which consequently led endoplasmic reticulum stress cell death. Inspiringly, injured hepatocyte could be rescued by remodeling via either supply fatty acids or enhancement Collectively, our study improves current understanding open opportunities for treatment.

Язык: Английский

Процитировано

30

Structural characteristics of a novel Bletilla striata polysaccharide and its activities for the alleviation of liver fibrosis DOI

Guanghui Jiang,

Bulei Wang,

Yuwen Wang

и другие.

Carbohydrate Polymers, Год журнала: 2023, Номер 313, С. 120781 - 120781

Опубликована: Март 9, 2023

Язык: Английский

Процитировано

29

Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications DOI Creative Commons
Yufei Liu,

Yuhong Zheng,

Yang Yang

и другие.

Frontiers in Immunology, Год журнала: 2023, Номер 14

Опубликована: Март 20, 2023

Liver fibrosis is a global health problem caused by chronic liver injury resulting from various factors. Hepatic stellate cells (HSCs) have been found to play major role in fibrosis, and pathological stimuli lead their transdifferentiation into myofibroblasts. Complex multidirectional interactions between HSCs, immune cells, cytokines are also critical for the progression of fibrosis. Despite advances treatments they do not meet current medical needs. Exosomes extracellular vesicles 30-150 nm diameter capable intercellular transport molecules such as lipids, proteins nucleic acids. As an essential mediator communication, exosomes involved physiological processes many diseases. In pathogenesis mainly regulating activation HSCs interaction cells. Serum-derived promising biomarkers therapeutic potential derived mesenchymal stem other exhibit anti-liver effects. Moreover, may serve targets hold promise becoming drug carriers treatment.

Язык: Английский

Процитировано

28

Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells DOI
Shenglong Xia,

Zimo Liu,

Jieru Cai

и другие.

Journal of Controlled Release, Год журнала: 2023, Номер 355, С. 54 - 67

Опубликована: Фев. 1, 2023

Язык: Английский

Процитировано

27